Cardiology-Atrial Fibrillation-DEEP

Title: Pivotal Study of a Dual Epicardial and Endocardial Procedure (DEEP) Approach For Treatment of Subjects With Persistent or Long-Standing Persistent Atrial Fibrillation With Radiofrequency Ablation
Description: The objective of this study is to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure for patients presenting with Persistent Atrial Fibrillation or Longstanding Persistent Atrial Fibrillation utilizing the AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System in an endoscopic or open ablation procedure, followed by an endocardial mapping and ablation procedure utilizing commercially available RF-based, irrigated, power controlled, ablation catheters for endocardial lesions. The endocardial procedure will be staged to occur after 90 days post epicardial surgical procedure.
Device: AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation
NCT Number: 02393885
Notes: The primary outcome for a patient is freedom from any documented AF, atrial flutter, or atrial tachycardia lasting >30 seconds in duration through the 12-month follow-up visit, in the absence of Class I or III AADs.
Start Date: 4/27/16
Status: On hold per FDA
Principal Name: Margot Vloka, MD
Contact Name: Jennifer Yehle, CRC
Phone: (208)302-0066